Session information

Symposium

[SY01] Symposium 1　Biomarkers of Immune checkpoint inhibitors in advanced NSCLC patients
【E】

Thu. Feb 17, 2022 8:30 AM - 10:00 AM Room 1 (Main Hall, 1F, Kyoto International Conference Center)

Chair：Makoto Nishio（Department of Thoracic medical Oncology, Japanese Foundation for Cancer Research），Tatsuya Yoshida（Department of Thoracic Oncology, National Cancer Center Hospital）

+Add all to schedule

[SY01-1] Novel therapies and Immunotherapy for small cell lung cancer: Finally, some progress

^○Roy S. Herbst (Yale Cancer Center | Yale School of Medicine)

[SY01-2] TBD

^○Mark Awad (Dana-Farber Cancer Institute)

[SY01-3] Gut microbiome as a potential biomarker of immunotherapy for advanced cancer ～ Can we just flush "it" away without examining "it" in detail? ～

^○Taiki Hakozaki (Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital)

[SY01-4] Blood biomarker to predict response to immunotherapy

^○Takehito Shukuya (Department of Respiratory Medicine, Juntendo University)

[SY01-5] Predictive biomarkers for cancer immunotherapy based on analysis of TILs

^○Shogo Kumagai (Division of Cellular Signaling National Cancer Center Research Institute)

▲